All type of patients: 2 trials - AMADEUS - idraparinux BOREALIS-AF
Primary prevention of thromboembolic events: 2 trials - AMADEUS - idraparinux BOREALIS-AF
All type of patients: 2 trials - VanGogh DVT - VanGogh PE
Patients with cancer: 1 trials - Van Gogh (subgroup)